lung cancer
Conditions
Interventions
Sponsors
Harbin Medical University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with a clinical diagnosis of non-small cell lung cancer and a clinical stage I, II or IIIa; 2. Pulmonary function tests with FEV1 > 1.5 L and greater than or equal to 50% of the expected value; 3. Aged 18-75 years (inclusive), regardless of gender; 4. Able to cooperate and complete follow-up visits and related examinations; 5. Voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Emergency surgery; 2. Combined with serious cardiovascular disease or serious heart, lung, liver, kidney and other major organ insufficiency, unable to perform surgical procedures; 3. Combined with severe coagulation dysfunction (APTT or PT > 1.5 times the normal value); 4. Combined with severe and uncontrolled hypertension (systolic blood pressure = 180 mmHg or diastolic blood pressure = 110 mmHg), diabetes mellitus (fasting blood glucose >= 10 mmol/L), hematologic disorders or immune system disorders; 5. Combined with surgical site or systemic infection, severe inflammatory reaction; 6. Combined with severe pleural adhesions, large pleural effusion; 7. Pregnant or lactating women; 8. ASA score greater than grade II; 9. Patients with combined severe mental illness who are unable to cooperate; 10. Patients participating in other investigational drug or device clinical trials that have not been completed; 11. Patients deemed by the investigator to be unsuitable for participation in this project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| successful operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of lymph node dissection;Surgeon satisfaction; | — |
Countries
China
Contacts
Public ContactXu Shidong
Harbin Medical University Cancer Hospital
Outcome results
None listed